Key Inclusions
- An executive summary of insights captured during our research. It offers a high-level view on the current state of the cell free expression market and its likely evolution in the given forecast period.
- A general overview of cell free system, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique. It also features applications of cell free expression in the healthcare industry, as well as other industries and a discussion on future prospects of cell free expression.
- A detailed assessment of the current market landscape of cell free expression service providers, based on several relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters, type of cell free service(s) offered (biomolecule synthesis / expression, template construction, scaled-up production, process optimization and feasibility testing), type of associated service(s) offered (purification, quality control and others), type of host organism (E. coli, wheat germ, HeLa / human cell lysate, rabbit reticulosyte, Nicotiana tabacum, Spodoptera frugiperda, Chinese hamster ovary, rice cell system, Saccharomyces cerevisiae and silkworm), type of product(s) synthesized (membrane proteins, toxic proteins, proteins with disulfide bonds / antibodies, protein complexes, soluble proteins, enzymes, modified proteins, antigens, insoluble proteins, high molecular weight proteins, other proteins, unspecified proteins and oligonucleotides), scale of operation (lab scale / pre-clinical, clinical and commercial) and type of industry served (pharmaceutical and biotechnology, academics, diagnostics, chemicals and food).
- A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters, such as type of cell free system (crude cell lysate-based systems and reconstituted systems), type of host organism (microbial cell free expression system, plant-based cell free expression system, mammalian cell free expression system and insect-based cell free expression system), type of expression method (coupled transcription and translation method and translation method), type of product(s) synthesized (toxic proteins, soluble proteins, membrane proteins, labeled proteins, functionally active proteins, proteins with disulfide bonds, proteins with unnatural amino acids, high molecular weight proteins, insoluble proteins, heat-sensitive proteins, enzymes, other proteins, unspecified proteins, oligonucleotides and whole cells), type of template(s) used (circular DNA, linear DNA, RNA and others), type of compatible promoter(s) (T7, SP6 and others), type of reaction format (batch format, bilayer format, CECF format, and batch and CECF format), yield of positive control (1-5 µg/mL, 5-100 µg/mL, 100-200 µg/mL, 200-500 µg/mL, 500-1,000 µg/mL, 1,000-2,000 µg/mL, 2,000-3,000 µg/mL and 3,000 µg/mL), reaction volume (1-5 µL, 5-100 µL, 100-200 µL, 200-500 µL, 500-1,000 µL, 1,000-2,000 µL, 2,000-3,000 µL, 3,000-10,000 µL and 10,000 µL), reaction temperature (20°C-25°C, 25°C-30°C, 30°C-35°C and 35°C-40°C), incubation time (1-2 hours, 2-10 hours, 10-20 hours and 20 hours), number of reactions per kit (1-5 reactions / kit, 5-20 reactions / kit, 20-50 reactions / kit, 50-80 reactions / kit and 80-100 reactions / kit), price per kit (USD 150-200, USD 200-500, USD 500-1,000, USD 1,000-2,000, USD 2,000-3,000, USD 3,000-4,000, USD 4,000-5,000 and USD 5,000). In addition, it provides details on cell free expression kits developers, along with analyses based on their year of establishment, company size (in terms of employee count), location of headquarters and leading players (in terms of number of kits provided).
- A comprehensive company competitiveness analysis of cell free expression service providers based on supplier power (in terms of number of years of experience) and service strength (in terms of type of host organism, service(s) offered, number of product(s) synthesized, industries served and scale of operation).
- A product competitiveness analysis of cell free expression kits based on various relevant parameters, namely developer power (in terms of number of years of experience) and product competitiveness (in terms of type of cell free system, type of expression method, type of host organism, number of product(s) synthesized, number of template(s) used, number of compatible promoter(s), yield of positive control (µg/ml), reaction volume (µl), incubation time (hours), type of reaction format, reaction temperature and number of reactions per kit).
- Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services. Each profile features a brief overview of the company, details on its cell free expression service portfolio, recent developments and an informed future outlook.
- Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion), featuring a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook.
- A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, since 2018, covering product development agreements, research and development agreements, technology licensing agreements, acquisitions, product licensing agreements, service alliances, asset acquisitions, joint ventures, product development and commercialization agreements, technology utilization agreements and other relevant agreements.
- An analysis of the funding and investments made in the market, since 2018, including seed financing, venture capital financing, capital raised from IPOs, secondary offerings, grants / awards, private placements, other equity and debt financing, at various stages of development in companies that are engaged in this field, based on several parameters, such as number of funding instances, amount invested, type of funding, leading players and investors, and geographical analysis.
- An in-depth analysis of various patents that have been filed / granted related to cell free system since 2015, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas, leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting leading patents (in terms of number of citations)..
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
- Type of Cell Free System
- Crude Cell Lysate-based Systems
- Reconstituted Systems
- Type of Host Organism
- Microbial Cell Free Expression Systems
- Mammalian Cell Free Expression Systems
- Plant-based Cell Free Expression Systems
- Other Cell Free Expression Systems
- Type of Expression Method
- Coupled Transcription and Translation Method
- Translation Method
- End-User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other End-Users
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Rest of the World
Key Questions Answered
- What is the likely growth rate (CAGR) of cell free expression market?
- How big is the cell free expression market?
- Who are the key players offering cell free expression services?
- Who are the key developers of cell free expression kits, globally?
- What are the common partnership trends observed related to cell free systems?
- Which region captures the largest share of the cell free expression market?
- Which segments account for the largest cell free expression market share?
For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html
News article
Biopharmaceutical Filtration Market
Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
